Filing Date Form TypeDescription   
   
2020-05-05DEFR14ARevised definitive proxy soliciting materialsAcc-no: 0001213900-20-010983 (34 Act)  Size: 2 MB
2020-04-29DEF 14AOther definitive proxy statementsAcc-no: 0001213900-20-010436 (34 Act)  Size: 2 MB
2019-04-26DEF 14AOther definitive proxy statementsAcc-no: 0001615774-19-006326 (34 Act)  Size: 783 KB
2018-04-26DEF 14AOther definitive proxy statementsAcc-no: 0001615774-18-002916 (34 Act)  Size: 551 KB


Sensus Healthcare Reports Second Quarter 2020 Financial Results
8/6/2020 8:02:00 PM

Conference call begins at 4:30 p.m. Eastern time today
Conference call begins at 4:30 p.m. Eastern time today

American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units
8/5/2020 12:30:00 PM

Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems


Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in Florida
8/4/2020 12:30:00 PM


Sensus Healthcare to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 6, 2020
7/30/2020 12:30:00 PM

BOCA RATON, Fla. , July 30, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 6, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter of 2020. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Sensus Healthcare Names Hoi-Bun “Benson” Suen Vice President of International Sales, Ships SRT-100™ to China
7/28/2020 12:30:00 PM

BOCA RATON, Fla. , July 28, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the appointment of Hoi-Bun “Benson” Suen as Vice President of International Sales.  Mr. Suen will focus on sales of the Company’s Superficial Radiation Therapy (SRT) products across Southeast Asia and will report directly to Joe Sardano, chief executive officer.  The Company is also announcing the resumption of shipments to China with the sale of an SRT-100™ system, a direct result of Mr. Suen’s efforts.


Evidence-Based Guidelines Issued by ASTRO Support Sensus Healthcare’s SRT Technology as the First-Line Alternative to Surgery for Treating Non-Melanoma Skin Cancer
7/14/2020 12:00:00 PM

Influential professional organization recommends radiotherapy as the primary non-surgical alternative for patients with basal cell or cutaneous squamous cell carcinomas


Sensus Healthcare to Present at COVID-19 Webinar Hosted by Maxim Group on July 16th
7/13/2020 8:02:00 PM

BOCA RATON, Fla., July 13, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, Sensus’ chief executive officer has been invited to present at the Re-Engaging Medical Practices in an Era of COVID-19  webinar, presented by Maxim Group and M-Vest on Thursday, July 16, 2020.


Sensus Healthcare’s CEO to Participate in Dermatology Practice Panel Discussion as Part of the Fall Clinical Virtual Grand Rounds Weekly Series
6/30/2020 12:30:00 PM

BOCA RATON, Fla. , June 30, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that Joe Sardano, the company’s chief executive officer, will participate in a panel discussion today at the Fall Clinical Virtual Grand Rounds Weekly Continuing Education Series. The program, titled “Directions in Dermatology and Their Impact on You: Patients, Practice and Pharma,” is part of the recent online series titled “Evolving Concepts in Dermatology; Dermatology Industry LeadersThe Path Forward.


Sensus Healthcare Announces CME Presentation by Dr. Jeffrey S. Fromowitz Today at the Fall Clinical Virtual Grand Rounds Series
6/24/2020 12:30:00 PM


Sensus Healthcare and David Goldberg, M.D., J.D. to Host a Virtual Program on Dermatology Medical and Legal Issues in the Era of COVID-19
6/3/2020 12:30:00 PM

June 18 Event is the Third in a Series of Topical Discussions


Sensus Healthcare Reports First Quarter 2020 Financial Results
5/7/2020 8:02:00 PM

Conference call begins at 4:30 p.m. Eastern time today
Conference call begins at 4:30 p.m. Eastern time today

Sensus Healthcare to Host First Quarter 2020 Financial Results and Business Update Conference Call on May 7, 2020
4/30/2020 12:00:00 PM

BOCA RATON, Fla. , April 30, 2020 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 7, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2020. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radiation Therapy in Journal of Drugs in Dermatology
3/3/2020 1:30:00 PM

Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT


Sensus Healthcare Reports Fourth Quarter and Full Year 2019 Financial Results
2/13/2020 9:02:00 PM

Fourth quarter net income up 10-fold to $1.0 million, diluted EPS of $0.06


Sensus Healthcare to Host Fourth Quarter 2019 Financial Results and Business Update Conference Call on February 13, 2020
2/6/2020 1:30:00 PM

BOCA RATON, Fla. , Feb. 06, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 13, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter and year ended December 31, 2019. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Sensus Healthcare Announces Sculptura™ Shipment to California-based Medical Center Third Sculptura system sold worldwide
1/22/2020 1:30:00 PM

BOCA RATON, Fla, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce it has shipped and installed a Sculptura™ radiation oncology system to Stanford Health Care in Palo Alto, Calif.  The system was shipped in December.  This is the third system to be shipped by Sensus and follows the sale of one system to Beilinson Hospital of the Rabin Medical Center in Israel and one to the University of Pennsylvania in Philadelphia. Sculptura received U.S. Food and Drug Administration 510(k) clearance in February 2019. 


Sensus Healthcare Announces Management Promotions
1/6/2020 9:05:00 PM

New corporate structure positions company for 2020 financial goals


Sensus Healthcare to Present at the Piper Jaffray 31st Annual Healthcare Conference
11/21/2019 1:30:00 PM

BOCA RATON, Fla., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Piper Jaffray 31st Annual Healthcare Conference on Thursday, December 5, 2019 at 8:30 a.m. Eastern time.  The conference will be held December 3-5, 2019 at the Lotte New York Palace Hotel in New York City.


Sensus Healthcare Reports Third Quarter 2019 Financial Results
11/6/2019 9:02:00 PM

Conference call begins at 4:30 p.m. Eastern time today


Sensus Healthcare to Host Third Quarter 2019 Financial Results and Business Update Conference Call on November 6, 2019
11/1/2019 1:57:00 PM

BOCA RATON, Fla., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter ended September 30, 2019. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference
May 15, 2019, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

Sensus Healthcare Reports First Quarter 2019 Financial Results
May 09, 2019, 16:02 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

Sensus Healthcare to Present at the 31st Annual ROTH Conference
Mar 13, 2019, 08:00 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

U.S. FDA Grants Market Clearance to Sensus Healthcare's New Sculptura™ Radiation Oncology System
Feb 26, 2019, 08:00 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

Sensus Healthcare to Host Fourth Quarter and Full Year 2018 Financial Results and Business Update Conference Call on February 14, 2019
Jan 30, 2019, 09:00 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Brings Groundbreaking SRT-100 Vision System to Israel's Largest Hospital for Skin Cancer and Keloid Treatment
Oct 17, 2018, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and...

Sensus Healthcare, Inc. Announces Commencement of Public Offering of Common Stock
Sep 12, 2018, 16:19 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share. B. Riley...

Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting
Sep 07, 2018, 08:04 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Second Quarter Financial Results Feature Continued Strong Revenue Growth
Aug 02, 2018, 16:01 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare to Host Second Quarter 2018 Financial Results and Business Update Conference Call on August 2, 2018
Jul 24, 2018, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology
Jul 12, 2018, 08:00 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and...

Sensus Healthcare to Join Russell Microcap® Index
Jun 25, 2018, 08:00 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit
Jun 12, 2018, 07:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth
May 03, 2018, 04:00 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement with Chindex Medical
Nov 01, 2017, 07:30 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico
Oct 31, 2017, 07:30 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids
Jul 26, 2017, 07:30 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Awarded 2017 Technology Leader of the Year for Disruptive Technology from Greater Miami Chamber of Commerce
May 24, 2017, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin...

Sensus Healthcare to Present at the 29th Annual ROTH Conference
Mar 07, 2017, 09:30 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, ...

Sensus Healthcare to Announce Fourth Quarter and Full Year 2016 Results on February 2, 2017
Jan 19, 2017, 07:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare to Participate in Annual JP Morgan Healthcare Conference Week on January 9th - 11th in San Francisco
Jan 03, 2017, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin...

Sensus Healthcare Receives the BioFlorida Company of the Year Award
Dec 13, 2016, 04:05 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin...

Sensus Healthcare Reports Third Quarter 2016 Results
Nov 03, 2016, 04:05 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award
Sep 07, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin...

Sensus Healthcare, Inc. Names Anthony Petrelli to its Board of Directors
Aug 02, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare, Inc. Units Separate; Trading of Common Stock and Warrants Commences
Jul 25, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare, Inc. Announces Separation of Units Sold in IPO
Jul 21, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare to Announce Second Quarter 2016 Results on August 4, 2016
Jul 20, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...